Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Clinical Trials Real-world data paints a different picture compared to the controlled environment of clinical trials
Product media carousel
When you have overweight or obesity, your heart has to work harder
In June 2025, Novo Nordisk, Pay a prepayment of $180 million (approximately RMB 1.293 billion) to Zhuhai United Laboratories in China to obtain global rights for its independently developed three target weight loss drug UBT251 outside of Greater China
Glucose-dependent insulinotropic polypeptide receptor therapies for the treatment of obesity, do agonists=antagonists
Individual factors like genetics, baseline nutrition, and overall health all play a role
US$ 27.16
US$ 20.58
US$ 28.67
